Takeda Says FDA Approves Treatment for Colorectal Cancer

Pharmaceutical company Takeda said Wednesday that the U.S. Food and Drug Administration approved Fruzaqla as a treatment for certain patients with colorectal...

Related Keywords

Japan ,Stephen Nakrosis ,Drug Administration ,Devices Agency ,Japan Pharmaceuticals ,European Medicines Agency ,Medical Devices Agency ,Article Normal ,Pharmaceuticals ,Cancer Drugs ,Healthcare Life Sciences ,Specialized Drugs Medications ,Regulation Government Policy ,New Products Services ,Product Service Approvals ,Corporate Industrial News ,Products Services ,Cancer ,Political General News ,Health ,Medical Conditions ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Takeda Pharmaceutical Co Ltd ,Jp 4502 ,Regulation ,Government Policy ,New Products ,Services ,Product ,Service Approvals ,Corporate ,Industrial News ,Products ,Political ,General News ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,